Asthma patients who are younger, have poor mental health, or are recently diagnosed have greater treatment needs,a German study found.
The use of preconditioned mesenchymal stem cells (MSCs) may offer a new, safer alternative to other cellular therapies used for tissue regeneration, according to recent study.
The Penn Medicine clinical trial uses kidneys from deceased donors who were infected with the hepatitis C virus. The first person in the trial received a kidney transplant in July and then underwent treatment with a regimen of Zepatier, one of the direct acting antiviral drugs approved recently to treat the virus.
In a potential future where 3D printing plays a large role in hospital medicine, pliable, bio-adaptive, custom bone transplants could be quickly printed using a new "ink" developed by researchers at Northwestern.
Panelists Peter L. Salgo, MD, and Joshua D. Lee, MD, PhD, provide insight on the risks of Vivitrol and any adherence considerations for patients with a history of substance abuse.
The MD Magazine editors rounded up the 10 best stories from September – did you read them all?
Peter Salgo, MD; Michael Felker, MD, MHS; Milton Packer, MD; Scott Solomon, MD; and John R. Teerlink, MD, share final thoughts on the management of patients with heart failure and describe their expectations for future innovation in the field.
Peter Salgo, MD; Michael Felker, MD, MHS; Milton Packer, MD; Scott Solomon, MD; and John R. Teerlink, MD, highlight the substantial benefits, but higher costs, of newer therapy options available for the treatment of heart failure. The panelists also discuss the role of the physician in providing cost-effective, quality care to their patients.
A considerable amount of progress has been made in battling the AIDS epidemic in recent years. However more work still needs to be done in certain patient populations.